Trevi Therapeutics Inc.(TRVI)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TRVI Trevi Therapeutics Inc.

交易中 05-21 14:22:57 EDT

2.77

-0.06

-2.12%

最高2.84	最低2.74	成交量3.33万
今开2.75	昨收2.83	日振幅3.53%
总市值1.95亿	流通市值1.13亿	总股本7,044万
成交额9.25万	换手率0.08%	流通股本4,083万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"TRVI","market":"US","secType":"STK","nameCN":"Trevi Therapeutics Inc.","latestPrice":2.77,"timestamp":1716315469540,"preClose":2.83,"halted":0,"volume":33342,"delay":0,"floatShares":40830751,"shares":70435093,"eps":-0.338162,"marketStatus":"交易中","marketStatusCode":2,"change":-0.06,"latestTime":"05-21 14:22:57 EDT","open":2.745,"high":2.84,"low":2.74,"amount":92480.8320996,"amplitude":0.035336,"askPrice":2.77,"askSize":383,"bidPrice":2.75,"bidSize":300,"shortable":3,"etf":0,"ttmEps":-0.338162,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1716321600000},"adr":0,"listingDate":1557201600000,"adjPreClose":2.83,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":2.83,"preClose":2.83,"latestTime":"08:35 EDT","volume":1,"amount":2.83,"timestamp":1716294929699},"postHourTrading":{"tag":"盘后","latestPrice":2.83,"preClose":2.83,"latestTime":"16:02 EDT","volume":754,"amount":2133.82,"timestamp":1716235328099},"volumeRatio":0.332481},"requestUrl":"/m/hq/s/TRVI","defaultTab":"news","newsList":[{"id":"2435379549","title":"Trevi Therapeutics, Inc.盘中异动 急速上涨5.49%报2.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435379549","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2435379549?lang=zh_cn&edition=full","pubTime":"2024-05-15 01:04","pubTimestamp":1715706262,"startTime":"0","endTime":"0","summary":"北京时间2024年05月15日01时04分，Trevi Therapeutics, Inc.股票出现异动，股价大幅拉升5.49%。Trevi Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.19%。Trevi Therapeutics, Inc.公司简介：Trevi Therapeutics Inc 是一家临床阶段的生物制药公司，专注于研究疗法 Haduvio的开发和商业化，用于治疗患有特发性肺纤维化或 IPF 的成人慢性咳嗽和其他慢性咳嗽适应症，以及用于 结节性痒疹的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405150104237a59dc97&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405150104237a59dc97&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2435374806","title":"Trevi Therapeutics, Inc.盘中异动 股价大跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435374806","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2435374806?lang=zh_cn&edition=full","pubTime":"2024-05-13 22:53","pubTimestamp":1715612036,"startTime":"0","endTime":"0","summary":"北京时间2024年05月13日22时53分，Trevi Therapeutics, Inc.股票出现波动，股价急速跳水5.13%。Trevi Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.19%。Trevi Therapeutics, Inc.公司简介：Trevi Therapeutics Inc 是一家临床阶段的生物制药公司，专注于研究疗法 Haduvio的开发和商业化，用于治疗患有特发性肺纤维化或 IPF 的成人慢性咳嗽和其他慢性咳嗽适应症，以及用于 结节性痒疹的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051322535787e878dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051322535787e878dc&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2435356931","title":"Trevi Therapeutics, Inc.2024财年第一财季实现净利润-10.90百万美元，同比减少70.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435356931","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2435356931?lang=zh_cn&edition=full","pubTime":"2024-05-13 00:19","pubTimestamp":1715530791,"startTime":"0","endTime":"0","summary":"3月31日，Trevi Therapeutics, Inc.公布财报，公告显示公司2024财年第一财季净利润为-10.90百万美元，同比减少70.31%；其中营业收入为0.00美元，每股基本收益为-0.11美元。从资产负债表来看，Trevi Therapeutics, Inc.总负债6.23百万美元，其中短期债务322000.00美元，资产负债比为12.61，流动比率为14.54。机构评级：截至2024年3月31日，当前有5家机构对Trevi Therapeutics, Inc.目标价做出预测，其中目标均价为7.40美元，其中最低目标价为6.00美元，最高目标价为9.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405130020018afe925c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405130020018afe925c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2434863330","title":"Trevi Therapeutics, Inc.盘中异动 早盘大幅跳水5.14%报2.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2434863330","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2434863330?lang=zh_cn&edition=full","pubTime":"2024-05-10 23:19","pubTimestamp":1715354349,"startTime":"0","endTime":"0","summary":"北京时间2024年05月10日23时19分，Trevi Therapeutics, Inc.股票出现异动，股价大幅跳水5.14%。Trevi Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.22%。Trevi Therapeutics, Inc.公司简介：Trevi Therapeutics Inc 是一家临床阶段的生物制药公司，专注于研究疗法 Haduvio的开发和商业化，用于治疗患有特发性肺纤维化或 IPF 的成人慢性咳嗽和其他慢性咳嗽适应症，以及用于 结节性痒疹的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405102319107a594385&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405102319107a594385&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2434101496","title":"Trevi Therapeutics, Inc.盘中异动 急速上涨5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434101496","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2434101496?lang=zh_cn&edition=full","pubTime":"2024-05-09 23:12","pubTimestamp":1715267538,"startTime":"0","endTime":"0","summary":"北京时间2024年05月09日23时12分，Trevi Therapeutics, Inc.股票出现异动，股价大幅拉升5.30%。Trevi Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.68%。Trevi Therapeutics, Inc.公司简介：Trevi Therapeutics Inc 是一家临床阶段的生物制药公司，专注于研究疗法 Haduvio的开发和商业化，用于治疗患有特发性肺纤维化或 IPF 的成人慢性咳嗽和其他慢性咳嗽适应症，以及用于 结节性痒疹的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240509231218861ec23c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240509231218861ec23c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433729363","title":"Trevi Therapeutics, Inc.盘中异动 股价大跌13.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433729363","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433729363?lang=zh_cn&edition=full","pubTime":"2024-05-08 21:31","pubTimestamp":1715175116,"startTime":"0","endTime":"0","summary":"北京时间2024年05月08日21时31分，Trevi Therapeutics, Inc.股票出现异动，股价急速下挫13.52%。Trevi Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.25%。其相关个股中，Repare Therapeutics Inc.、Cel-Sci Corporation、内克塔治疗涨幅较大，Enveric Biosciences, Inc.、Allarity Therapeutics, Inc.、Clearmind Medicine Inc.较为活跃，换手率分别为198.84%、24.98%、10.33%，振幅较大的相关个股有Veru Inc.、Adaptive Biotechnologies Corporation、Rani Therapeutics Holdings, Inc.，振幅分别为9.20%、8.62%、8.58%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050821315687e09635&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050821315687e09635&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432810819","title":"Trevi Therapeutics, Inc.盘中异动 临近午盘大幅拉升6.29%报3.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432810819","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432810819?lang=zh_cn&edition=full","pubTime":"2024-05-02 23:57","pubTimestamp":1714665451,"startTime":"0","endTime":"0","summary":"北京时间2024年05月02日23时57分，Trevi Therapeutics, Inc.股票出现波动，股价大幅拉升6.29%。Trevi Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.64%。Trevi Therapeutics, Inc.公司简介：Trevi Therapeutics Inc 是一家临床阶段的生物制药公司，专注于研究疗法 Haduvio的开发和商业化，用于治疗患有特发性肺纤维化或 IPF 的成人慢性咳嗽和其他慢性咳嗽适应症，以及用于 结节性痒疹的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405022357317a57ee16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405022357317a57ee16&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431815385","title":"Trevi Therapeutics, Inc.盘中异动 下午盘股价大涨5.13%报2.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431815385","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431815385?lang=zh_cn&edition=full","pubTime":"2024-04-30 01:04","pubTimestamp":1714410266,"startTime":"0","endTime":"0","summary":"北京时间2024年04月30日01时04分，Trevi Therapeutics, Inc.股票出现异动，股价急速上涨5.13%。Trevi Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.82%。Trevi Therapeutics, Inc.公司简介：Trevi Therapeutics Inc 是一家临床阶段的生物制药公司，专注于研究疗法 Haduvio的开发和商业化，用于治疗患有特发性肺纤维化或 IPF 的成人慢性咳嗽和其他慢性咳嗽适应症，以及用于 结节性痒疹的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240430010427861ea240&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240430010427861ea240&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430616788","title":"Trevi Therapeutics, Inc.盘中异动 急速上涨7.09%报2.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430616788","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430616788?lang=zh_cn&edition=full","pubTime":"2024-04-27 00:20","pubTimestamp":1714148458,"startTime":"0","endTime":"0","summary":"北京时间2024年04月27日00时20分，Trevi Therapeutics, Inc.股票出现异动，股价大幅上涨7.09%。Trevi Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。Trevi Therapeutics, Inc.公司简介：Trevi Therapeutics Inc 是一家临床阶段的生物制药公司，专注于研究疗法 Haduvio的开发和商业化，用于治疗患有特发性肺纤维化或 IPF 的成人慢性咳嗽和其他慢性咳嗽适应症，以及用于 结节性痒疹的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042700205879240c39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042700205879240c39&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430289020","title":"Trevi Therapeutics, Inc.盘中异动 早盘急速下跌5.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430289020","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430289020?lang=zh_cn&edition=full","pubTime":"2024-04-25 21:54","pubTimestamp":1714053256,"startTime":"0","endTime":"0","summary":"北京时间2024年04月25日21时54分，Trevi Therapeutics, Inc.股票出现异动，股价急速下挫5.85%。Trevi Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.34%。Trevi Therapeutics, Inc.公司简介：Trevi Therapeutics Inc 是一家临床阶段的生物制药公司，专注于研究疗法 Haduvio的开发和商业化，用于治疗患有特发性肺纤维化或 IPF 的成人慢性咳嗽和其他慢性咳嗽适应症，以及用于 结节性痒疹的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404252154167923779f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404252154167923779f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429113132","title":"Trevi Therapeutics, Inc.盘中异动 早盘股价大涨5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429113132","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429113132?lang=zh_cn&edition=full","pubTime":"2024-04-23 22:05","pubTimestamp":1713881156,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日22时05分，Trevi Therapeutics, Inc.股票出现异动，股价急速上涨5.44%。Trevi Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.39%。Trevi Therapeutics, Inc.公司简介：Trevi Therapeutics Inc 是一家临床阶段的生物制药公司，专注于研究疗法 Haduvio的开发和商业化，用于治疗患有特发性肺纤维化或 IPF 的成人慢性咳嗽和其他慢性咳嗽适应症，以及用于 结节性痒疹的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232205577922b21c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232205577922b21c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428657825","title":"Trevi Therapeutics, Inc.盘中异动 早盘股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428657825","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428657825?lang=zh_cn&edition=full","pubTime":"2024-04-19 21:58","pubTimestamp":1713535122,"startTime":"0","endTime":"0","summary":"北京时间2024年04月19日21时58分，Trevi Therapeutics, Inc.股票出现波动，股价急速拉升5.03%。Trevi Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.85%。Trevi Therapeutics, Inc.公司简介：Trevi Therapeutics Inc 是一家临床阶段的生物制药公司，专注于研究疗法 Haduvio的开发和商业化，用于治疗患有特发性肺纤维化或 IPF 的成人慢性咳嗽和其他慢性咳嗽适应症，以及用于 结节性痒疹的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404192158427921e231&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404192158427921e231&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427878629","title":"Trevi Therapeutics, Inc.盘中异动 早盘股价大跌5.34%报2.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427878629","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427878629?lang=zh_cn&edition=full","pubTime":"2024-04-16 22:02","pubTimestamp":1713276173,"startTime":"0","endTime":"0","summary":"北京时间2024年04月16日22时02分，Trevi Therapeutics, Inc.股票出现异动，股价快速跳水5.34%。截至发稿，该股报2.66美元/股，成交量5857股，换手率0.01%，振幅2.49%。Trevi Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.50%。Trevi Therapeutics, Inc.公司简介：Trevi Therapeutics Inc 是一家临床阶段的生物制药公司，专注于研究疗法 Haduvio的开发和商业化，用于治疗患有特发性肺纤维化或 IPF 的成人慢性咳嗽和其他慢性咳嗽适应症，以及用于 结节性痒疹的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041622025387e80fd0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041622025387e80fd0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427024300","title":"Trevi Therapeutics, Inc.盘中异动 早盘股价大跌5.48%报2.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427024300","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427024300?lang=zh_cn&edition=full","pubTime":"2024-04-15 22:43","pubTimestamp":1713192183,"startTime":"0","endTime":"0","summary":"北京时间2024年04月15日22时43分，Trevi Therapeutics, Inc.股票出现波动，股价大幅下跌5.48%。Trevi Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.42%。Trevi Therapeutics, Inc.公司简介：Trevi Therapeutics Inc 是一家临床阶段的生物制药公司，专注于研究疗法 Haduvio的开发和商业化，用于治疗患有特发性肺纤维化或 IPF 的成人慢性咳嗽和其他慢性咳嗽适应症，以及用于 结节性痒疹的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404152243047a52dde8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404152243047a52dde8&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424443038","title":"Trevi Therapeutics, Inc.盘中异动 早盘大幅下跌5.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2424443038","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424443038?lang=zh_cn&edition=full","pubTime":"2024-04-03 22:12","pubTimestamp":1712153555,"startTime":"0","endTime":"0","summary":"北京时间2024年04月03日22时12分，Trevi Therapeutics, Inc.股票出现波动，股价快速下跌5.57%。Trevi Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.25%。其相关个股中，方舟生物医药、Kintara Therapeutics, Inc.、Vanda Pharmaceuticals Inc.涨幅较大，Kintara Therapeutics, Inc.、方舟生物医药、Vanda Pharmaceuticals Inc.较为活跃，换手率分别为385.22%、264.59%、38.86%，振幅较大的相关个股有Kintara Therapeutics, Inc.、方舟生物医药、Vanda Pharmaceuticals Inc.，振幅分别为69.52%、53.80%、42.46%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404032212357a50f9ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404032212357a50f9ca&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.trevitherapeutics.com","stockEarnings":[{"period":"1week","weight":0.0366},{"period":"1month","weight":-0.0018},{"period":"3month","weight":0.0328},{"period":"6month","weight":1.4825},{"period":"1year","weight":0.1792},{"period":"ytd","weight":1.1119}],"compareEarnings":[{"period":"1week","weight":0.0176},{"period":"1month","weight":0.0705},{"period":"3month","weight":0.067},{"period":"6month","weight":0.1649},{"period":"1year","weight":0.2662},{"period":"ytd","weight":0.1152}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Trevi Therapeutics, Inc.于2011年3月17日根据特拉华州法律注册成立。该公司是一家临床阶段的生物制药公司，专注于开发和商业化纳布啡ER，以治疗严重的神经介导的疾病。公司目前正在开发纳布啡ER，用于治疗患有特发性肺纤维化或IPF的慢性瘙痒，慢性咳嗽，以及帕金森病患者的左旋多巴诱导的运动障碍或LID。这些病症具有共同的病理生理学，其通过中枢和外周神经系统中的阿片受体介导。由于纳布啡作为阿片受体调节剂的作用机制，该公司认为它有可能有效治疗这些疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.8,"avgChangeRate":0.128325},{"month":2,"riseRate":0.8,"avgChangeRate":0.214835},{"month":3,"riseRate":0.4,"avgChangeRate":0.397594},{"month":4,"riseRate":0.4,"avgChangeRate":0.130673},{"month":5,"riseRate":0,"avgChangeRate":-0.125018},{"month":6,"riseRate":0.8,"avgChangeRate":0.295237},{"month":7,"riseRate":0.2,"avgChangeRate":-0.102824},{"month":8,"riseRate":0.2,"avgChangeRate":-0.104475},{"month":9,"riseRate":0,"avgChangeRate":-0.155733},{"month":10,"riseRate":0.2,"avgChangeRate":-0.120785},{"month":11,"riseRate":0.2,"avgChangeRate":-0.086318},{"month":12,"riseRate":0.6,"avgChangeRate":-0.027412}],"exchange":"NASDAQ","name":"Trevi Therapeutics Inc.","nameEN":"Trevi Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Trevi Therapeutics Inc.(TRVI)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Trevi Therapeutics Inc.(TRVI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Trevi Therapeutics Inc.,TRVI,Trevi Therapeutics Inc.股票,Trevi Therapeutics Inc.股票老虎,Trevi Therapeutics Inc.股票老虎国际,Trevi Therapeutics Inc.行情,Trevi Therapeutics Inc.股票行情,Trevi Therapeutics Inc.股价,Trevi Therapeutics Inc.股市,Trevi Therapeutics Inc.股票价格,Trevi Therapeutics Inc.股票交易,Trevi Therapeutics Inc.股票购买,Trevi Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Trevi Therapeutics Inc.(TRVI)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Trevi Therapeutics Inc.(TRVI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}